Cargando…

Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis

BACKGROUND: We have found that acetate supplementation significantly reduces neuroglia activation and pro-inflammatory cytokine release in a rat model of neuroinflammation induced with lipopolysaccharide. To test if the anti-inflammatory effect of acetate supplementation is specific to a TLR4-mediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Brissette, Catherine A, Houdek, Heidi M, Floden, Angela M, Rosenberger, Thad A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520777/
https://www.ncbi.nlm.nih.gov/pubmed/23134838
http://dx.doi.org/10.1186/1742-2094-9-249
_version_ 1782252828990898176
author Brissette, Catherine A
Houdek, Heidi M
Floden, Angela M
Rosenberger, Thad A
author_facet Brissette, Catherine A
Houdek, Heidi M
Floden, Angela M
Rosenberger, Thad A
author_sort Brissette, Catherine A
collection PubMed
description BACKGROUND: We have found that acetate supplementation significantly reduces neuroglia activation and pro-inflammatory cytokine release in a rat model of neuroinflammation induced with lipopolysaccharide. To test if the anti-inflammatory effect of acetate supplementation is specific to a TLR4-mediated injury, we measured markers of neuroglia activation in rats subjected to B. burgdorferi-induced neuroborreliosis that is mediated in large part by a TLR2-type mechanism. METHODS: In this study, rats were subjected to Lyme neuroborreliosis following an intravenous infusion of B. burgdorferi (B31-MI-16). Acetate supplementation was induced using glyceryl triacetate (6g/kg) by oral gavage. Immunohistochemistry, qPCR, and western blot analyses were used to measure bacterial invasion into the brain, neuroglial activation, and brain and circulating levels of interleukin 1β. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by a Tukey’s post hoc tests or using a Student’s t test assuming unequal variances when appropriate. RESULTS: We found that acetate supplementation significantly reduced microglia activation by 2-fold as determined by immunohistochemical and western blot analysis. Further, acetate supplementation also reduced the expression of the pro-inflammatory cytokine IL-1β by 2-fold as compared to controls. On the other hand, the inoculation of rats with B. burgdorferi had no effect on astroglial activation as determined by immunocytochemistry and western blot analysis despite significant increases in circulation levels of antigen toward B. burgdorferi and presence of the bacteria in the central nervous system. CONCLUSIONS: These results suggest that microglial activation is an essential component to neuroborreliosis and that acetate supplementation may be an effective treatment to reduce injury phenotype and possibly injury progression in Lyme neuroborreliosis.
format Online
Article
Text
id pubmed-3520777
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35207772012-12-13 Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis Brissette, Catherine A Houdek, Heidi M Floden, Angela M Rosenberger, Thad A J Neuroinflammation Research BACKGROUND: We have found that acetate supplementation significantly reduces neuroglia activation and pro-inflammatory cytokine release in a rat model of neuroinflammation induced with lipopolysaccharide. To test if the anti-inflammatory effect of acetate supplementation is specific to a TLR4-mediated injury, we measured markers of neuroglia activation in rats subjected to B. burgdorferi-induced neuroborreliosis that is mediated in large part by a TLR2-type mechanism. METHODS: In this study, rats were subjected to Lyme neuroborreliosis following an intravenous infusion of B. burgdorferi (B31-MI-16). Acetate supplementation was induced using glyceryl triacetate (6g/kg) by oral gavage. Immunohistochemistry, qPCR, and western blot analyses were used to measure bacterial invasion into the brain, neuroglial activation, and brain and circulating levels of interleukin 1β. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by a Tukey’s post hoc tests or using a Student’s t test assuming unequal variances when appropriate. RESULTS: We found that acetate supplementation significantly reduced microglia activation by 2-fold as determined by immunohistochemical and western blot analysis. Further, acetate supplementation also reduced the expression of the pro-inflammatory cytokine IL-1β by 2-fold as compared to controls. On the other hand, the inoculation of rats with B. burgdorferi had no effect on astroglial activation as determined by immunocytochemistry and western blot analysis despite significant increases in circulation levels of antigen toward B. burgdorferi and presence of the bacteria in the central nervous system. CONCLUSIONS: These results suggest that microglial activation is an essential component to neuroborreliosis and that acetate supplementation may be an effective treatment to reduce injury phenotype and possibly injury progression in Lyme neuroborreliosis. BioMed Central 2012-11-07 /pmc/articles/PMC3520777/ /pubmed/23134838 http://dx.doi.org/10.1186/1742-2094-9-249 Text en Copyright ©2012 Brissette et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Brissette, Catherine A
Houdek, Heidi M
Floden, Angela M
Rosenberger, Thad A
Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
title Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
title_full Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
title_fullStr Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
title_full_unstemmed Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
title_short Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
title_sort acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of lyme neuroborreliosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520777/
https://www.ncbi.nlm.nih.gov/pubmed/23134838
http://dx.doi.org/10.1186/1742-2094-9-249
work_keys_str_mv AT brissettecatherinea acetatesupplementationreducesmicrogliaactivationandbraininterleukin1blevelsinaratmodeloflymeneuroborreliosis
AT houdekheidim acetatesupplementationreducesmicrogliaactivationandbraininterleukin1blevelsinaratmodeloflymeneuroborreliosis
AT flodenangelam acetatesupplementationreducesmicrogliaactivationandbraininterleukin1blevelsinaratmodeloflymeneuroborreliosis
AT rosenbergerthada acetatesupplementationreducesmicrogliaactivationandbraininterleukin1blevelsinaratmodeloflymeneuroborreliosis